Home/Filings/4/0001104659-25-020516
4//SEC Filing

BATOR MICHAEL G. 4

Accession 0001104659-25-020516

CIK 0001175151other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 9:00 PM ET

Size

15.4 KB

Accession

0001104659-25-020516

Insider Transaction Report

Form 4
Period: 2025-02-24
Transactions
  • Exercise Out-of-Money

    Common Stock

    2025-02-24$1.13/sh+10,000$11,300151,273 total
  • Exercise Out-of-Money

    Series A Right Warrants (right to buy)

    2025-02-24$1.13/sh15,879$17,9430 total
    Exercise: $1.13From: 2025-01-17Exp: 2025-02-24Common Stock (15,879 underlying)
Footnotes (4)
  • [F1]On January 17, 2025, the Reporting Person exercised certain subscription rights certificates received pursuant to a rights offering (the "Rights Offering") with CytoSorbents Corporation (the "Issuer") whereby the Reporting Person received Units consisting of an aggregate of 15,879 (i) shares of Issuer's common stock, par value $0.001 per share (the "Common Stock"), (ii) Series A Warrants to purchase one share of Common Stock, and (iii) Series B Warrants to purchase one share of Common Stock, at a subscription purchase price of $1.00 per unit for an aggregate cost of $15,879. The Rights Offering closed on January 10, 2025 (the "Closing Date").
  • [F2]The Series A Right Warrants exercise price was calculated as 90% of the 5-day volume weighted average price of the Issuer's Common Stock over the 5-trading days prior to the expiration date of the Series A Right Warrants, rounded down to the nearest whole cent but (x) not lower than $1.00 and (y) not higher than $2.00.
  • [F3]Includes (a) the following restricted stock units ("RSUs") which will vest upon a "Change of Control" of the Company, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (i) 3,300 RSUs granted on March 15, 2018, (ii) 6,000 RSUs granted on February 24, 2017, and (iii) 60,000 RSUs granted on June 7, 2016, and (b) 81,973 shares of Common Stock owned by the Reporting Person.
  • [F4]The Reporting Person's remaining 5,879 Series A Warrants expired unexercised on February 24, 2025.

Issuer

Cytosorbents Corp

CIK 0001175151

Entity typeother

Related Parties

1
  • filerCIK 0001647591

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 9:00 PM ET
Size
15.4 KB